Pfizer Inc. is recalling approximately 269 bottles of Caduet (amlodipine besylate/atorvastatin calcium) tablets because they may have been packaged in defective bottles with notched rims. This physical defect can prevent the foil seal from closing properly, potentially exposing the medication to moisture and compromising its effectiveness or stability. The recall affects 30-count bottles of two different dosage strengths distributed nationwide. If you have this medication, you should contact your doctor or pharmacist to discuss your treatment and return the affected product to the pharmacy for a refund.
A notched rim on the medication bottle can cause an inadequate foil seal, allowing moisture to enter the container. This moisture can degrade the active ingredients in the medication, potentially making it less effective at treating high blood pressure and high cholesterol.
Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.